Growing evidence suggests that endocannabinoid levels are modulated during pathological conditions affecting both central and peripheral nervous system.In the present study, a novel approach (patent pending) based on an Windows innovative liquid biosensor has been used to analyze two relevant endocannabinoid molecules with calibration purposes: N-arachidonoylethanolamine and 2-arachidonoylglycerol.The system was able to predict both FLIR Camera compound concentrations with a Root Mean Square Error in Cross Validation (RMSECV) of 6.61 nM and 23.
50 nM, respectively.